Home monitoring in Idiopathic Pulmonary Fibrosis: improving use of anti-fibrotic medication and quality of life

Dataset

DOI

This was a multicenter randomised controlled trial on the effects of a home monitoring program on quality of life and medication use in patients with idiopathic pulmonary fibrosis. Patients were randomized (1:1) to standard care alone or a home monitoring program on top of standard care for 24 weeks. The primary outcome was between-group change in score of the validated K-BILD questionnaire. This dataset contains the metadata of the study.

Date: 31-08-2019

Date: 2018-01-09

Date Submitted: 2020-12-08

Identifier
DOI	https://doi.org/10.17026/dans-244-6anu
Metadata Access	https://lifesciences.datastations.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.17026/dans-244-6anu

Provenance
Creator	C.C. Moor
Publisher	DANS Data Station Life Sciences
Contributor	C.C. Moor; Erasmus Medical Center
Publication Year	2021
Rights	CC-BY-NC-4.0; info:eu-repo/semantics/restrictedAccess; http://creativecommons.org/licenses/by-nc/4.0
OpenAccess	false
Contact	C.C. Moor (Erasmus Medical Center)

Representation
Resource Type	Dataset
Format	application/zip; application/pdf; text/csv
Size	17873; 1247177; 55815; 29447; 158640; 686743; 533458; 4271
Version	1.1
Discipline	Life Sciences; Medicine